Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prognostic value of immune cells in the tumor microenvironment of early-stage lung cancer: a meta-analysis
Stephanie Tuminello, Rajwanth Veluswamy, Wil Lieberman‐Cribbin, et al.
Oncotarget (2019) Vol. 10, Iss. 67, pp. 7142-7155
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

NK cell infiltration is associated with improved overall survival in solid cancers: A systematic review and meta-analysis
Sarah Nersesian, Sarah L. Schwartz, Stephanie R. Grantham, et al.
Translational Oncology (2020) Vol. 14, Iss. 1, pp. 100930-100930
Open Access | Times Cited: 143
EGFR-Mutated Non-Small Cell Lung Cancer and Resistance to Immunotherapy: Role of the Tumor Microenvironment
Clelia Madeddu, Clelia Donisi, Nicole Liscia, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 12, pp. 6489-6489
Open Access | Times Cited: 82
Non-small cell lung carcinoma (NSCLC): Implications on molecular pathology and advances in early diagnostics and therapeutics
Hafiza Padinharayil, Jinsu Varghese, Mithun Chacko John, et al.
Genes & Diseases (2022) Vol. 10, Iss. 3, pp. 960-989
Open Access | Times Cited: 68
Methods to Determine and Analyze the Cellular Spatial Distribution Extracted From Multiplex Immunofluorescence Data to Understand the Tumor Microenvironment
Edwin R. Parra
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 60
Tumor Immune Microenvironment and Immunotherapy in Non-Small Cell Lung Cancer: Update and New Challenges
Shuqin Xing, Kaiwen Hu, Yafei Wang
Aging and Disease (2022) Vol. 13, Iss. 6, pp. 1615-1615
Open Access | Times Cited: 46
Cellular and Molecular Profiling of Tumor Microenvironment and Early-Stage Lung Cancer
Radu Pîrlog, Paul Chiroi, Ioana Rusu, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 10, pp. 5346-5346
Open Access | Times Cited: 30
Image‐based multiplex immune profiling of cancer tissues: translational implications. A report of the International Immuno‐oncology Biomarker Working Group on Breast Cancer
Chowdhury Arif Jahangir, David B. Page, Glenn Broeckx, et al.
The Journal of Pathology (2024) Vol. 262, Iss. 3, pp. 271-288
Open Access | Times Cited: 6
NFE2L2/KEAP1 Mutations Correlate with Higher Tumor Mutational Burden Value/PD-L1 Expression and Potentiate Improved Clinical Outcome with Immunotherapy
Xian Xu, Yang Yang, Xiaoyan Liu, et al.
The Oncologist (2020) Vol. 25, Iss. 6, pp. e955-e963
Open Access | Times Cited: 48
Prognostic significance of spatial immune profiles in human solid cancers
Takahiro Tsujikawa, Junichi Mitsuda, Hiroshi Ogi, et al.
Cancer Science (2020) Vol. 111, Iss. 10, pp. 3426-3434
Open Access | Times Cited: 48
Molecular biomarkers in early stage lung cancer
M. Fernández Rodríguez, Daniel Ajona, Luis Seijó, et al.
Translational Lung Cancer Research (2021) Vol. 10, Iss. 2, pp. 1165-1185
Open Access | Times Cited: 40
Relationship between Tumor Infiltrating Immune Cells and Tumor Metastasis and Its Prognostic Value in Cancer
Huan-Xiang Li, Shuqi Wang, Zhengxing Lian, et al.
Cells (2022) Vol. 12, Iss. 1, pp. 64-64
Open Access | Times Cited: 25
A tri-specific killer engager against mesothelin targets NK cells towards lung cancer
Philippa R Kennedy, Daniel A. Vallera, Brianna Ettestad, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 15
PD-L1 as a prognostic biomarker in surgically resectable non- small cell lung cancer: a meta-analysis
Stephanie Tuminello, Daniel Sikavi, Rajwanth Veluswamy, et al.
Translational Lung Cancer Research (2020) Vol. 9, Iss. 4, pp. 1343-1360
Open Access | Times Cited: 38
Current literature review on the tumor immune micro-environment, its heterogeneity and future perspectives in treatment of advanced non-small cell lung cancer
Jeong Uk Lim, Eunyoung Lee, Sang‐Yun Lee, et al.
Translational Lung Cancer Research (2023) Vol. 12, Iss. 4, pp. 857-876
Open Access | Times Cited: 11
Exploring lung cancer microenvironment: pathways and nanoparticle-based therapies
Arunabh Arandhara, Pallabi Bhuyan, Bhrigu Kumar Das
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Neoadjuvant and Adjuvant Immunotherapy in Early-Stage Non-Small Cell Lung Cancer
Nikhil Shukla, Nasser H. Hanna
Lung Cancer Targets and Therapy (2021) Vol. Volume 12, pp. 51-60
Open Access | Times Cited: 26
Positive Allosteric Modulation of CD11b as a Novel Therapeutic Strategy Against Lung Cancer
Terese Geraghty, Anugraha Rajagopalan, Rabail Aslam, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 24
The prognostic role of M2 tumor-associated macrophages in non-small-cell lung cancer.
Zhuo Li, Yunjie Wang, Jian Zhou, et al.
PubMed (2022) Vol. 37, Iss. 12, pp. 1167-1175
Closed Access | Times Cited: 12
Intratumoral versus Circulating Lymphoid Cells as Predictive Biomarkers in Lung Cancer Patients Treated with Immune Checkpoint Inhibitors: Is the Easiest Path the Best One?
Marta Gascón Ruiz, Dolores Isla, Mara Cruellas, et al.
Cells (2020) Vol. 9, Iss. 6, pp. 1525-1525
Open Access | Times Cited: 18
Multidimensional profiling depicts infiltrating immune cell heterogeneity in the tumor microenvironment of stage IA non‐small cell lung cancer
Jin Duan, Guoli Lv, Nanye Zhu, et al.
Thoracic Cancer (2022) Vol. 13, Iss. 7, pp. 947-955
Open Access | Times Cited: 10
Host-Related Factors as Targetable Drivers of Immunotherapy Response in Non-Small Cell Lung Cancer Patients
Denisa Baci, Elona Cekani, Andrea Imperatori, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 10
Mapping Immune–Tumor Bidirectional Dialogue Using Ultrasensitive Nanosensors for Accurate Diagnosis of Lung Cancer
Swarna Ganesh, Priya Dharmalingam, Sunit Das, et al.
ACS Nano (2023) Vol. 17, Iss. 9, pp. 8026-8040
Closed Access | Times Cited: 5
It might be a dead end: immune checkpoint inhibitor therapy in EGFR-mutated NSCLC
Ken Akao, Yuko Oya, Takaya Sato, et al.
Exploration of Targeted Anti-tumor Therapy (2024) Vol. 5, Iss. 4, pp. 826-840
Open Access | Times Cited: 1
Comprehensive analysis of microenvironment-related genes in lung adenocarcinoma
Ye Tao, Bin Liang, Yunhui Li
Future Oncology (2020) Vol. 16, Iss. 24, pp. 1825-1837
Closed Access | Times Cited: 11
Tumor Microenvironment CD14+ Cells Correlate with Poor Overall Survival in Patients with Early-Stage Lung Adenocarcinoma
Erin L. Schenk, Jennifer M. Boland, Sarah G. Withers, et al.
Cancers (2022) Vol. 14, Iss. 18, pp. 4501-4501
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top